Rockwell Medical Inc (RMTI)
1.58
-0.05
(-3.07%)
USD |
NASDAQ |
May 03, 16:00
1.59
+0.01
(+0.63%)
After-Hours: 20:00
Rockwell Medical Cash from Operations (Quarterly): -0.043M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.043M |
| September 30, 2023 | -3.753M |
| June 30, 2023 | -1.74M |
| March 31, 2023 | -3.876M |
| December 31, 2022 | -0.112M |
| September 30, 2022 | -1.102M |
| June 30, 2022 | -5.904M |
| March 31, 2022 | -9.811M |
| December 31, 2021 | -9.026M |
| September 30, 2021 | -7.075M |
| June 30, 2021 | -4.938M |
| March 31, 2021 | -12.50M |
| December 31, 2020 | -8.569M |
| September 30, 2020 | -4.918M |
| June 30, 2020 | -9.616M |
| March 31, 2020 | -6.538M |
| December 31, 2019 | -5.30M |
| September 30, 2019 | -6.176M |
| June 30, 2019 | -10.35M |
| March 31, 2019 | -5.424M |
| December 31, 2018 | -5.784M |
| September 30, 2018 | -4.779M |
| June 30, 2018 | -5.250M |
| March 31, 2018 | -4.607M |
| December 31, 2017 | -4.810M |
| Date | Value |
|---|---|
| September 30, 2017 | -4.185M |
| June 30, 2017 | -7.041M |
| March 31, 2017 | -5.077M |
| December 31, 2016 | 0.5378M |
| September 30, 2016 | -6.696M |
| June 30, 2016 | -5.229M |
| March 31, 2016 | -1.066M |
| December 31, 2015 | 0.2116M |
| September 30, 2015 | -3.837M |
| June 30, 2015 | -6.389M |
| March 31, 2015 | -3.314M |
| December 31, 2014 | 17.56M |
| September 30, 2014 | 0.314M |
| June 30, 2014 | -3.246M |
| March 31, 2014 | -10.37M |
| December 31, 2013 | -8.143M |
| September 30, 2013 | -9.688M |
| June 30, 2013 | -21.53M |
| March 31, 2013 | -11.31M |
| December 31, 2012 | -7.171M |
| September 30, 2012 | -8.791M |
| June 30, 2012 | -6.484M |
| March 31, 2012 | -8.302M |
| December 31, 2011 | -3.534M |
| September 30, 2011 | -2.291M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-12.50M
Minimum
Mar 2021
-0.043M
Maximum
Dec 2023
-5.860M
Average
-5.904M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | -3.91M |
| Oragenics Inc | -1.102M |
| Alpine Immune Sciences Inc | -18.97M |
| Corvus Pharmaceuticals Inc | -5.167M |
| MAIA Biotechnology Inc | -3.992M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 2.008M |
| Cash from Financing (Quarterly) | -0.742M |
| Free Cash Flow | -9.696M |
| Free Cash Flow Per Share (Quarterly) | -0.003 |
| Free Cash Flow to Equity (Quarterly) | 0.827M |
| Free Cash Flow Yield | -26.37% |